The β3-Adrenergic System and β3-Adrenergic Agonists

被引：22
|
作者：
Arch J.R.S. [1 ]
机构：
[1] GlaxoSmithKline, Harlow, Essex, CM19 5AD, New Frtrs. Sci. Pk. N., Cldhbr. Rd.
来源：
Reviews in Endocrine and Metabolic Disorders | 2001年 / 2卷 / 4期
关键词：
β[!sub]3[!/sub]-adrenergic; β[!sub]3[!/sub]-adrenoceptor agonists; β[!sub]4[!/sub]-adrenoceptor; Diabetes; Obesity; Thermogenesis;
D O I：
10.1023/A:1011852500209
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：385 / 393
页数：8
相关论文
共 50 条
  • [1] The use of β3-adrenergic receptor agonists in the treatment of heart failure
    Rasmussen, Helge H.
    Figtree, Gemma A.
    Krum, Henry
    Bundgaard, Henning
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 955 - 962
  • [2] Potent, selective agonists of the human β3-adrenergic receptor.
    Solvibile, WR
    Ashwell, MA
    Molinari, AJ
    Han, S
    Largis, E
    Mulvey, R
    Tillet, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U645 - U645
  • [3] Potent benzimidazolone based human β3-adrenergic receptor agonists
    Finley, Don R.
    Bell, Michael G.
    Borel, Anthony G.
    Bloomquist, William E.
    Cohen, Marlene L.
    Heiman, Mark. L.
    Kriauciunas, Aidas
    Matthews, Donald P.
    Miles, Tania
    Neel, David A.
    Rito, Christopher J.
    Sall, Daniel J.
    Shuker, Anthony J.
    Stephens, Thomas W.
    Tinsley, Frank C.
    Winter, Mark A.
    Jesudason, Cynthia D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5691 - 5694
  • [4] Physiology and pathophysiology of the β3-adrenergic receptor
    Yang, Li-Kun
    Tao, Ya-Xiong
    G PROTEIN SIGNALING PATHWAYS IN HEALTH AND DISEASE, 2019, 161 : 91 - 112
  • [5] Might β3-adrenergic receptor agonists be useful in disorders of glucose homeostasis?
    Flier, Jeffrey S.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05): : 2180 - 2182
  • [6] Recent developments in the design of orally bioavailable β3-adrenergic receptor agonists
    Sawa, M
    Harada, H
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (01) : 25 - 37
  • [7] Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs.: I.: The presence of canine β3-adrenergic receptor and in vivo lipomobilization by its agonists
    Sasaki, N
    Uchida, E
    Niiyama, M
    Yoshida, T
    Saito, M
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1998, 60 (04): : 459 - 463
  • [8] Mutated human β3-adrenergic receptor (Trp64Arg) lowers the response to β3-adrenergic agonists in transfected 3T3-L1 preadipocytes
    Kimura, K
    Sasaki, N
    Asano, A
    Mizukami, J
    Kayahashi, S
    Kawada, T
    Fushiki, T
    Morimatsu, M
    Yoshida, T
    Saito, M
    HORMONE AND METABOLIC RESEARCH, 2000, 32 (03) : 91 - 96
  • [9] β3-adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human β3-adrenergic receptor
    Tavernier, G
    Toumaniantz, G
    Erfanian, M
    Heymann, MF
    Laurent, K
    Langin, D
    Gauthier, C
    CARDIOVASCULAR RESEARCH, 2003, 59 (02) : 288 - 296
  • [10] Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists
    Maruyama, Tatsuya
    Onda, Kenichi
    Hayakawa, Masahiko
    Matsui, Tetsuo
    Takasu, Toshiyuki
    Ohta, Mitsuaki
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (06) : 2533 - 2543
12345